Fri.Nov 29, 2019

article thumbnail

The FDA Issues Hemp-CBD Warning Letters and a Consumer Update

Canna Law Blog

The Food and Drug Administration (“FDA”) had a busy Monday this week. On November 25, the agency issued warning letters to 15 businesses selling hemp-derived CBD (“Hemp-CBD”) products as unapproved drugs. The FDA also released updated consumer guidance on Hemp-CBD. Warning Letters. The recent batch of warning letters appear to turn on the marketing of Hemp-CBD products as unapproved drugs.

Hemp 137
article thumbnail

Quebec looks into same-day delivery to battle illicit market

Leafly

Hoping to compete with an entrenched legacy market composed largely of delivery services, the SQDC wants to introduce delivery within 24 hours. The post Quebec looks into same-day delivery to battle illicit market appeared first on Leafly.

117
117
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why People Choose THC Oil: Its Benefits and Effects

Cannabis Law Report

Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. But, this is just one of the more than 400 compounds that are found in cannabis. But, this compound has other benefits and effects other than being the one that makes a user high. What is Tetrahydrocannabinol? THC is the psychoactive compound in cannabis. That’s why it is responsible for the high feeling a person gets after using marijuana.

Oil 104
article thumbnail

Quebec’s Couche Tard convenience plans to bid on Cannabis NB

Leafly

The retail chain with assets including Circle K and Mac’s Milk convenience stores, has been eager to get into legal cannabis retail for years. The post Quebec’s Couche Tard convenience plans to bid on Cannabis NB appeared first on Leafly.

Retail 113
article thumbnail

Where the Money Grows: Learning the Industry Trends in Medical Cannabis, Recreational Marijuana, Hemp, and Beyond

Speaker: Jonathan Bench, International Cannabis and Securities Business Attorney at Harris Bricken

The U.S. cannabis industry is still in its infancy, even though states began engaging with legalization in one form or another in the late 1990s. Today, many opportunities exist for individuals and businesses that want to engage in the industry. Some want to directly own licensed businesses, while others prefer to keep the industry at an arm’s length and merely profit from it.

article thumbnail

How CBD:THC Blends Work: Half Baked – Exploring the Biases of NAM

Cannabis Life Network

CBD has become a global phenomenon, whether as a medicine or just a dietary supplement. In reality, a lot of therapeutic effects that people are buying into are really just placebo effects. With that being said, CBD does heal and help with many conditions, especially epilepsy. Many will justly recommend a full-spectrum product to get […]. The post How CBD:THC Blends Work: Half Baked – Exploring the Biases of NAM appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Sto

More Trending

article thumbnail

Today’s Answer of the Day

TheAnswerPage

Excluding potential drug:drug interactions, what adverse effects of CBD have been noted in clinical trials? In clinical trials evaluating CBD, adverse effects, including diarrhea, somnolence, decreased appetite, change in weight, and increased levels of liver enzymes have been noted. Of note, the one FDA-approved CBD product is associated with a higher risk of hepatotoxicity necessitating recommended scheduled liver function testing in patients starting the medication.

article thumbnail

European Medicinal Cannabis Association (EUMCA) Say Germany Has The Cannabis Model The EU Should Adopt

Cannabis Law Report

Euractiv report… Germany’s regulatory approach to medical cannabis is good practice and should be replicated across Europe, according to newly-born European Medicinal Cannabis Association (EUMCA). The recently established lobby group is taking its first steps in the Brussels bubble, advocating for an EU-wide regulatory framework on medical marijuana.

article thumbnail

New York Times: Wave of European Cannabis Firms to List in 2020, Analyst Says

Cannabis Law Report

LONDON — Up to five companies active in the cannabis industry could go public in 2020 in Europe, a continent whose stock markets have largely missed out on the North-American “pot stocks” frenzy, a leading industry analyst said on Thursday. …/… “I think there will be 4 or 5 companies quoted in twelve months time”, Nikolaas Faes, an analysts for Bryan Garnier told Reuters on the sidelines of a cannabis industry conference.

article thumbnail

Weed and mental health – everything you should know

Cannabis Law Report

The cannabis plant contains more than 500 identified chemical constituents. More than 100 of them are cannabinoids. Medical marijuana uses the cannabis plant or its basic chemicals to treat a whole bunch of different diseases and conditions. Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. When cannabinoids enter the human body, they start interacting with the endocannabinoid system which is the network of cell receptors throughout the brain and b

article thumbnail

UK Firm Mackrell Upgrades Cannabis Team

Cannabis Law Report

Here’s the press release.